Associated Papers
Unraveling the Oncogenic Potential of VAV1 in Human Cancer: Lessons from Mouse Models.
Shalom B et al.
Cells, 2023
Naturally Occurring Genetic Alterations in Proximal TCR Signaling and Implications for Cancer Immunotherapy.
Kent A et al.
Frontiers in Immunology, 2021
Vav1 mutations: What makes them oncogenic?
Farago M et al.
Cellular Signalling, 2020
Vav1 mutations identified in human cancers give rise to different oncogenic phenotypes.
Shalom B et al.
Oncogenesis, 2018
Vav1: A Dr. Jekyll and Mr. Hyde protein--good for the hematopoietic system, bad for cancer.
Katzav S
Oncotarget, 2015
Select a paper to view details